| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |